Suppr超能文献

新型杂环磺酰基 - 羧基亚胺酰胺的合成、结构及生物活性

Synthesis, structure, and biological activity of novel heterocyclic sulfonyl-carboximidamides.

作者信息

Gobis Katarzyna, Foks Henryk, Sławiński Jarosław, Sikorski Artur, Trzybiński Damian, Augustynowicz-Kopeć Ewa, Napiórkowska Agnieszka, Bojanowski Krzysztof

机构信息

Department of Organic Chemistry, Medical University of Gdańsk, Gdańsk, Poland.

Department of Physical Chemistry, University of Gdańsk, Gdańsk, Poland.

出版信息

Monatsh Chem. 2013;144(5):647-658. doi: 10.1007/s00706-012-0888-0. Epub 2013 Jan 25.

Abstract

ABSTRACT

A series of novel heterocyclic sulfonyl-carboximidamides were synthesized in satisfactory yields via condensation of heterocyclic methyl carbimidates with 2-chlorobenzenesulfonamide and 4-chloropyridine-3-sulfonamide. New structures were confirmed by IR and NMR spectra as well as elemental analyses. X-ray crystallography of two derivatives was performed. The single-crystal structures confirmed the presence of a primary amine group in the amidine moiety. All the compounds were screened for their tuberculostatic, antibacterial, and anticancer activities. Preliminary results indicated that target compounds exhibited weak tuberculostatic and antibacterial activities. Seven compounds inhibited the growth of some cancer cell lines, whereas one of the 2-quinoline derivatives displayed favorable activity against all tested cancer cells with values of 0.92-13 μM.

摘要

摘要

通过杂环氨基甲酸甲酯与2-氯苯磺酰胺和4-氯吡啶-3-磺酰胺缩合,以令人满意的产率合成了一系列新型杂环磺酰基-羧脒。通过红外光谱、核磁共振光谱以及元素分析确定了新结构。对两种衍生物进行了X射线晶体学分析。单晶结构证实了脒部分中存在伯胺基团。对所有化合物进行了抗结核、抗菌和抗癌活性筛选。初步结果表明,目标化合物表现出较弱的抗结核和抗菌活性。七种化合物抑制了某些癌细胞系的生长,而2-喹啉衍生物之一对所有测试癌细胞均显示出良好的活性,其IC₅₀值为0.92 - 13 μM。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce3/4494771/2e6bf1247dae/706_2012_888_Sch1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验